Amolyt Pharma to Participate at Three Upcoming Investor Conferences

3 years ago

LYON, France and CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic…

Coherus BioSciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 17th, 2022

3 years ago

REDWOOD CITY, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its fourth quarter…

Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan

3 years ago

U.S. FDA clears IND to evaluate MET642 for the treatment of ulcerative colitisSufficient capital to complete Phase 2 IBD trial…

NRx Reports Remarks by Israel Institute for Biological Research on the future of the BriLife™ Covid-19 Investigational Vaccine

3 years ago

Remarks by Dr. Shmuel Yitzhaki, as published in Globes, an Israeli business newspaperBriLife vaccine may have better neurtralizing ability against…

VIVO Cannabis(TM) Adds Assuage Suppositories to Online Medical Marketplace

3 years ago

Toronto, Ontario--(Newsfile Corp. - February 11, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a…

BTIG to Host Virtual Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference on February 15-17, 2022

3 years ago

Firm Event to Attract More than 125 Industry-Leading and Emerging Healthcare Companies NEW YORK--(BUSINESS WIRE)--BTIG announced today the “BTIG Snowbird…

Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months; Provides 2022 Business Outlook

3 years ago

The world’s first and only long-term implantable CGM system now offers patients exceptional accuracy for 6 months GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics…

NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR(TM) in Head and Neck Squamous Cell Carcinoma

3 years ago

RaDaR demonstrated 100% specificity in patients with no recurrence and 100% sensitivity in patients with clinical recurrenceFT MYERS, FL /…

Zynx Health Ranked #1 for Clinical Decision Support – Care Plans and Order Sets in KLAS Research’s 2022 Best in KLAS Report

3 years ago

LOS ANGELES--(BUSINESS WIRE)--#bestinklass--Zynx Health, a pioneer and market leader in evidence- and experience-based clinical solutions, has been ranked #1 in…

Better For You Wellness Announces Results from Its February 5, 2022, Board of Directors Meeting

3 years ago

Better For You Wellness Establishes Strategic Advisory Committee with Industry Leaders and MoreColumbus, Ohio--(Newsfile Corp. - February 10, 2022) -…